Resistant Hypertension: An Update

Am J Hypertens. 2019 Jan 1;32(1):1-3. doi: 10.1093/ajh/hpy156.

Authors

David A Calhoun¹, Ernesto L Schiffrin², John M Flack³

Affiliations

¹ Department of Medicine, Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, Alabama, USA.
² Lady Davis Institute of Medical Research, and Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
³ Division of General Medicine, Hypertension Section, Department of Medicine, Springfield, Illinois, USA.

PMID: 30407514
DOI: 10.1093/ajh/hpy156

No abstract available

Publication types

Editorial

MeSH terms

Antihypertensive Agents / therapeutic use*
Blood Pressure / drug effects*
Consensus
Drug Resistance*
Drug Therapy, Combination
Humans
Hypertension / diagnosis
Hypertension / drug therapy*
Hypertension / epidemiology
Hypertension / physiopathology
Prevalence
Risk Factors
Terminology as Topic
Treatment Failure

Substances

Antihypertensive Agents

Associated data

ClinicalTrials.gov/NCT02649426
ClinicalTrials.gov/NCT03179800